Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2021250012) titled 'A Phase III Clinical Trial of Photodynamic Diagnosis with SPP-005 in Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer' on Aug. 4.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, diagnostic purpose
Primary Sponsor: Yataba Ikuko
Condition:
Ovarian, Fallopian Tube, or Peritoneal Cancer
Intervention:
Administer 20 mg/kg of aminolevulinic acid hydrochloride orally, dissolved in water 2-8 hours prior to induction of anesthesia.
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 01/10/2025
Target Sa...